Dermata Therapeutics Inc. (DRMA)
1.38
-0.06 (-4.17%)
At close: Jan 15, 2025, 3:59 PM
1.39
0.72%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -7.79M | -9.61M | -7.90M | -3.24M | -4.72M |
| Depreciation & Amortization | n/a | n/a | n/a | 322.00 | 1.35K |
| Stock-Based Compensation | 522.08K | 930.33K | 1.91M | n/a | 730.96 |
| Other Working Capital | 494.35K | -135.03K | -121.42K | -522.94K | -197.41K |
| Other Non-Cash Items | n/a | 930.33K | 14.13K | -36.49K | 872.72K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -730.96 |
| Change in Working Capital | 863.68K | -153.58K | 289.55K | -755.85K | -74.99K |
| Operating Cash Flow | -6.41M | -8.83M | -5.69M | -4.03M | -3.92M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | 1.01M | -676.59K | -626.17K |
| Common Stock Repurchased | -40 | n/a | -1.00M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 187.00 | 287.00 | -430.00K | 3.24M | 5.36M |
| Financial Cash Flow | 7.61M | 4.28M | 15.96M | 2.57M | 4.73M |
| Net Cash Flow | 1.20M | -4.56M | 10.27M | -1.46M | 812.19K |
| Free Cash Flow | -6.41M | -8.83M | -5.69M | -4.03M | -3.92M |